BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 8.81 Delayed Data As of Jun 08 |  0.00 / 0.00%Today’s Change | 7.20 Today|||52-Week Range 15.43 | -23.26% Year-to-Date |
Latest BCRX News | Press Releases
No recent news for BioCryst Pharmaceuticals Inc.
Today’s Trading
| Previous close | 8.81 |
| Today’s open | 8.82 |
| Day’s range | 8.75 - 8.96 |
| Volume | 1,955,846 |
| Average volume (3 months) | 2,825,778 |
| Market cap | $1.6B |
Data as of 4:00pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | -29.35% |
| Earnings growth (this year) | +27.89% |
| Earnings growth (next 5 years) | +36.84% |
| Revenue growth (last year) | +72.31% |
| P/E ratio | NM |
| Price/Sales | 7.88 |
| Price/Book | -- |
Competitors
Data as of 3:59pm ET, 06/08/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $270.8M |
| Annual profit (last year) | -$247.1M |
| Net profit margin | -91.24% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
